Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 24Recruiting 9Unknown 3Not yet recruiting 3Active not recruiting 3Withdrawn 2Terminated 2

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 10Gastrointestinal 3Head & Neck 1Genitourinary 1

Conditions

Colorectal Neoplasms 307Pancreatic Neoplasms 207Stomach Neoplasms 161Carcinoma, Hepatocellular 160Colonic Neoplasms 115Rectal Neoplasms 104Esophageal Neoplasms 92Carcinoma, Non-Small-Cell Lung 91Breast Neoplasms 76Neoplasms 67Liver Neoplasms 62Ovarian Neoplasms 60Melanoma 51Neoplasm Metastasis 50Cholangiocarcinoma 49Lung Neoplasms 48Squamous Cell Carcinoma of Head and Neck 37Esophageal Squamous Cell Carcinoma 37Gastrointestinal Neoplasms 36Carcinoma, Renal Cell 35Prostatic Neoplasms 33Uterine Cervical Neoplasms 32Sarcoma 32Endometrial Neoplasms 32Biliary Tract Neoplasms 31Anus Neoplasms 30Head and Neck Neoplasms 27Urinary Bladder Neoplasms 22Triple Negative Breast Neoplasms 21Adenocarcinoma Of Esophagus 21

Interventions

entinostat 1bintrafusp alfa protein, human 1Vaccines 1Surveys and Questionnaires 1Papillomavirus Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Vaginal Neoplasms × Gastrointestinal × Clear all
NCT04713618 2026-05-07

GEORGIA

Ohio State University Comprehensive Cancer Center

Active not recruiting
72 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT04708470 2026-04-06

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
55 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05662020 2022-12-27

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Beijing Health Guard Biotechnology, Inc

Phase 3 Active not recruiting
2,750 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡